HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Analysis of the bone anabolic agent by intravital imaging technique.]

Abstract
Teriparatide, recombinant human PTH(1-34), is the only anabolic agent widely used for osteoporosis. This drug is thought to promote bone formation by modulating bone remodeling system, although the detailed mechanism remains unclear. Recently, we developed a novel intravital imaging technique to visualize mature osteoclasts and mature osteoblasts simultaneously. By means of this system, we revealed the effect of teriparatide on three-dimensional distribution and cell-to-cell interactions between these cells. Advances in these imaging studies may lead to further understanding of the intercellular network in bone metabolism.
AuthorsAkito Morimoto, Junichi Kikuta, Masayuki Furuya, Masaru Ishii
JournalClinical calcium (Clin Calcium) 2018 Vol. 28 Issue 2 Pg. 243-248 ISSN: 0917-5857 [Print] Japan
PMID29371491 (Publication Type: Journal Article)
Chemical References
  • Anabolic Agents
Topics
  • Anabolic Agents (pharmacology)
  • Animals
  • Bone Remodeling
  • Bone and Bones (cytology, drug effects, physiology)
  • Humans
  • Intravital Microscopy
  • Osteoblasts (drug effects)
  • Osteoclasts (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: